Sodium hydride → HCID 86616961, compound
Reaction equation
[Br:1][C:2]1[N:3]=[C:4]([C:9]2[CH:14]=[CH:13][C:12]([Cl:15])=[CH:11][CH:10]=2)[C:5]([NH2:8])=[N:6][CH:7]=1.[H-].[Na+].Br[CH2:19][CH2:20][CH2:21][CH2:22][CH2:23]Cl>CN(C)C=O>[Br:1][C:2]1[N:3]=[C:4]([C:9]2[CH:10]=[CH:11][C:12]([Cl:15])=[CH:13][CH:14]=2)[C:5]([N:8]2[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]2)=[N:6][CH:7]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 0.5 g (0.0018 mol) 5-bromo-3-(4-chloro-phenyl)-pyrazin-2-ylamine in 10 ml dimethylformamide was added at room temperature 0.240 g sodium hydride 55% in oil (0.006 mol) and 0.49 g 1-bromo-5-chloro-pentane (0.0025 mol) and the mixture was stirred at room temperature for 0.5 hours. Another 0.130 g sodium hydride 55% in oil was added and the mixture was stirred at room temperature for 2.5 h. The resulting mixture was partitioned between 10% aqueous citric acid and ethyl acetate. The phases were separated, the organic phase was dried over magnesium sulfate and evaporated. The residue was purified by chromatography on silica gel using a gradient of 30% ethyl acetate in heptane to ethyl acetate to yield 0.043 g (83% yield) of the title compound as slightly brownish oil. MS (ISP) (M+H+)=354.1 and 356.0.
Workup
- stirringthe mixture was stirred at room temperature for 2.5 h
- customThe resulting mixture was partitioned between 10% aqueous citric acid and ethyl acetate
- customThe phases were separated
- dry with materialthe organic phase was dried over magnesium sulfate
- customevaporated
- customThe residue was purified by chromatography on silica gel using a gradient of 30% ethyl acetate in heptane to ethyl acetate
Sources & evidence
- ORD record
- ord-c00a429616be4122bfd83738f42abeed
- Source dataset
- uspto-grants-2009_12
- Patent number
- US07629346B2
Reaction notes
Loading…